RE44
- for Cellbiology
- Specification Assay :
- 97.0+% (HPLC)
- Manufacturer :
- FUJIFILM Wako Pure Chemical Corporation
- Storage Condition :
- Keep at -20 degrees C.
- CAS RN® :
- 1361122-24-8
- Molecular Formula :
- C28H43NO5
- Molecular Weight :
- 473.64
- Structural Formula
- Label
- Packing
- SDS
|
Comparison
|
Product Number
|
Package Size
|
Price
|
Availability
|
Certificate of Analysis
|
Purchase |
|---|---|---|---|---|---|---|
|
|
|
1mg
|
|
Out of Stock |
※Check availability in the US with the distributor.
Document
Application
Overview / Applications
| Outline | This product is for research use only. Do not administer it to human. In many signal transduction cascades, phosphorylation (protein kinase) and dephosphorylation (protein phosphatase) of proteins are involved in cascade regulation. This product is an inhibitor that specifically inhibits protein phosphatase CDC25B (cell division cycle 25B), a dual specific protein phosphatase targeting phosphorylated serine, threonine, and tyrosine. There are CDC25A, CDC25B, CDC25C isoforms in human. CDC25A and CDC25B have been reported to be overexpressed in various cancer cells such as lung, stomach, and pancreatic cancer. This product is an inhibitor that does not act on CDC25C, but acts selectively on CDC25B and CDC25A. Inhibitory activity : ID50=4.26 umol/L (CDC25B), 13.5 umol/L (CDC25A) [24.9 umol/L (VHR)] 1) Tsuchiya, A. et al., "Dual-specificity phosphatase CDC25A/B inhibitor identified from a focused library with nonelectropholic core structure.", ACS Med. Chem. Lett., 3, 294-298 (2012). 2) Tsuchiya, A. et al., "CDC25A-inhibitory RE derivatives bind to pocket adjacent to the catalytic site.", Mol. BioSyst., 9, 1026-1034 (2013). |
|---|
Property
| Appearance | White - slightly brown, crystals - powder or paste |
|---|
Manufacturer Information
Alias
- 3-[1-(2-Hydroxybenzylamino)hexadecylidene]-5-(hydroxymethyl)furan(3H,5H)-2,4-dione
For research use or further manufacturing use only. Not for use in diagnostic procedures.
Product content may differ from the actual image due to minor specification changes etc.
If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.